Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Legislation

Bill to Permit Drug Court Completion with Medication-Assisted Treatment Heads to Governor Christie

Trenton, NJ, June 29, 2015 ― Legislation sponsored by Assembly Democrats Herb Conaway M.D., Raj Mukherji, Shavonda Sumter and Angelica Jimenez to permit successful completion of drug court programs notwithstanding use of medication-assisted treatment was approved 76-0 Thursday by the Assembly, giving it final legislative approval.

The bill now goes to Governor Chris Christie for consideration.

The bill (A3723) concerns the use of medication-assisted treatment by individuals involved in the state’s special probation drug court program as an alternative to incarceration. Continue reading

Bill to Make Cost-Effective Biological Drug Alternatives More Widely Available Heads to Governor

Trenton, NJ, June 28, 2015 ― Legislation sponsored by Assembly Democrats Pamela Lampitt, Herb Conaway, Jr., M.D., Daniel Benson, Shavonda Sumter, Angel Fuentes and Nancy Pinkin to make it easier for consumers to obtain more cost-effective, “generic” versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer was approved 75-0 Thursday by the Assembly, giving it final legislative approval.

The bill now goes to the governor. Continue reading

Bipartisan Bill Package to Prevent Prescription Drug & Opioid Abuse Gains Panel Approval

Trenton, NJ, December 4, 2014 ― Bipartisan legislation to help address the prescription drug and opioid abuse epidemic plaguing New Jersey was advanced today by an Assembly panel.

Part of an ongoing effort to create awareness, prevent abuse and promote recovery, the five measures collectively represent a comprehensive solution to a multi-faceted problem. Continue reading

Bills to Overhaul Business Incentives on Hold for Now

Trenton, NJ, March 18, 2013 — Joshua Burd reports in NJBIZ that closely watched bills that would reshape the state’s business and development incentives will have to wait until at least early May, their two top sponsors said on Friday, as lawmakers fine-tune the measures while getting through several weeks of budget hearings.

However, the sponsors, Assemblyman Albert Coutinho (D-Newark) and Sen. Raymond Lesniak (D-Union), remain confident about the future of the legislation, with the effort garnering broad support and two related bills clearing their respective committees earlier this week. Continue reading